
Tin prices have been climbing sharply because the metal is suddenly caught between rising demand and tightening supply. Electronic devices, artificial intelligence hardware, solar panels and electric vehicles all rely on tin-based solder and components, pushing consumption higher just as long-neglected supply struggles to keep up. Production has been disrupted in key regions by political instability, mine closures and regulatory crackdowns, and underinvestment means new sources aren’t coming online fast enough. In this article we discuss some of the ASX stocks that can benefit the most from the rising tin prices.

The Australian share market has a habit of sending quiet signals before a move actually happens. One of the most reliable of those signals is bullish divergence, a moment when price looks weak, but momentum quietly starts to improve. In this article, we’ll take a closer look at three stocks listed on the (ASX) that are currently showing confirmed bullish divergence patterns.

Every so often, the market serves up a handful of charts that practically nudge you to take a closer look. You know the type, steady higher lows, clean breakouts, and that subtle shift in momentum that hints at a story unfolding beneath the surface. In this piece, we’re turning the spotlight on three ASX-listed stocks whose price action has been speaking in a clear and confident tone. These aren’t wild speculative swings or one-off spikes; they’re structured uptrends that have earned their place on watchlists through consistent behaviour.

We believe National Australia Bank (ASX: NAB) is entering a structurally more attractive phase of its earnings cycle, one that the market is only partially pricing. FY25 confirms that NAB has completed a difficult multi-year transition from remediation-heavy execution towards balance-sheet-led growth, operational leverage, and disciplined capital deployment. In our view, National Australia Bank is no longer just a “solid major bank.” It is increasingly a business-banking-centric compounder, with improving margin resilience, strengthening deposit mix, stabilising asset quality, and credible technology-driven productivity optionality.

We believe CSL Limited (ASX: CSL) remains one of the highest-quality global healthcare franchises listed on the ASX, with FY25 marking a clear re-acceleration in earnings quality, cash flow conversion, and strategic clarity. While the share price has periodically struggled to reflect this underlying strength, we view CSL as misunderstood rather than mis-executing.

We believe Collins Foods (ASX: CKF) is entering a multi-year earnings recovery cycle anchored by margin repair in Australia, operational rejuvenation in Europe, clear line-of-sight to double-digit EBITDA growth, and an improving balance sheet that gives management options rather than constraints. The HY26 results demonstrate that CKF is moving decisively out of the inflation shock period that suppressed margins and elevated operating costs between 2022–2024. With commodity and utilities inflation easing, labour efficiencies improving, and price/mix still resilient, we see structural tailwinds forming beneath the company’s operating base.